XML 84 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations - Schedule of Book Value of Assets and Liabilities (Details) - USD ($)
Dec. 27, 2023
Dec. 31, 2022
Discontinued Operations    
Cash and cash equivalents   $ 5,242,840
Discontinued Operations, Disposed of by Sale | Elusys Therapeutics    
Discontinued Operations    
Cash and cash equivalents $ 252,423  
Prepaid expenses and deposits 30,228  
Intangibles and other long-term assets 6,728,109  
Accounts payable (197,082)  
Accrued expenses and other liabilities (1,183,129)  
Contingent royalty earnout liability (4,610,000)  
Net book value of assets and liabilities sold $ 1,020,549